ASP Isotopes Inc. Common Stock (ASPI)
FairStock Score: 36/100 — MIXED
Key Financials
| Current Price | $1.95 |
| Market Cap | $298M |
| P/E Ratio | -1.35 |
| ROE | -90.35% |
| Dividend Yield | —% |
| Sector | Basic Materials |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At $2.28 on 2026-10-13, ASP Isotopes has a $349.5M market capitalization. It is a development-stage advanced materials company producing isotopes, with a Nuclear Fuels segment aimed at HALEU and Lithium-6 for advanced nuclear fuels. The strategic appeal is real: nuclear fuel supply is sensitive, and technical and regulatory barriers can create a moat. But a moat is not yet visible in the financials. In fiscal 2025, ended 2025-12-31, revenue was $23.8M and net loss was $159.8M, or diluted EPS of -$2.11. In fiscal Q2 2026, ended 2026-06-30, revenue was $5.1M and net loss was $34.0M. Revenue is growing from a small base—FY2024 revenue was $4.1M—but cash consumption is severe: FairStock's trailing free cash flow was -$83.6M and FCF yield was -23.9%. FairStock's Piotroski F-Score is 2/9 and Altman Z-Score is 0.27, signaling weak financial health. Debt/equity is 0.98; FairStock's ROE is -90.35% and ROCE is -17.01%, so capital is being consumed, not compounded. Valuation offers little earnings support: FairStock's P/E is -1.58 and P/B is 1.12. The $349.5M market cap is about 15 times FY2025 revenue, a rich multiple for a loss-making, cash-burning business. The Lynch category is none because losses occurred in each of the last four years. I prefer durable earnings and predictable cash; ASPI may be an option on nuclear-fuel scarcity, but it is not a Graham-style bargain. It is a speculative development-stage equity, and its beta of 3.60 and 52-week range of $2.25-$13.19 show how volatile sentiment can be.
In plain English: ASP Isotopes makes specialized isotopes for nuclear fuel and other uses. The business looks weak today: it is still losing money and using cash, with losses in recent years. At $2.28, the price is near its 52-week low, but because the company has no earnings, it is hard to call the stock cheap or expensive based on its current numbers.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash
Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)
Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer